Optimum Perspectives

Lytix Biopharma – Innovations in Killing Cancer


Listen Later

Following recent encouraging interim clinical results, hear Øystein Rekdal, CEO of Lytix Biopharma, discuss with Optimum's Nick Bastin how the company's lead candidate LTX-315 has a unique approach to killing cancer.

Hosted on Acast. See acast.com/privacy for more information.

...more
View all episodesView all episodes
Download on the App Store

Optimum PerspectivesBy Optimum Strategic Communications